Opinion: B.C. EV sales mandate risks redundancy as Ottawa changes course - Business in Vancouver

AcknowledgementsThe authors thank UCLA's Institute for Digital Research and Education (IDRE), Michigan Technological University's MRI computing clusters, and the National Energy Research Scientific Computing Center (NERSC) for providing computational resources. The authors thank Abhishek Keripale for assistance with the development of later versions of the CrFeCoNi machine-learning models. The authors used GPT-5 (OpenAI) for language editing and proofreading and subsequently reviewed and edited all content. FundingThis work was primarily supported by the U. S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES), under Award DE-SC0023432, which provided primary support for the overall project conception and integrated KS-DFT–ML investigations. The University of California National Laboratory Fees Research Program under Grant L25CR9003 supported data generation and post-processing at UCLA (ASB). The National Science Foundation under Award 2442313 supported data-pruning and dimensionality analyses at Michigan Technological University (SG, SH). This research also used resources of the National Energy Research Scientific Computing Center (NERSC), a U. S.

The same patient, identified and re-consented for the third or fourth time across separate studies, is not an edge case. It is how clinical research is currently structured, and the inefficiency is measurable: every redundant records request, re-registration, and repeat consent conversation adds cost to the sponsor and time to a patient already managing a demanding diagnosis. The case building around patient-owned health data argues that the architecture itself is the problem, not the execution. The traditional model treats each protocol as a discrete relationship. A trial opens, participants are found, data flows inward, and the relationship ends. But sponsors rarely stop needing evidence from the same populations once a study closes. Observational work, real-world outcomes, label extensions, and post-market commitments all draw on the same patient groups, rebuilt from scratch each time. What the patient-owned model proposes instead is a single consented relationship that persists across those activities, turning what was an episodic research interaction into ongoing infrastructure.

The S&P/TSX Composite jumped 1.4 per cent for the trading week ending with Friday’s close and is now 16.1 per cent higher for 2026. The benchmark’s Relative Strength Index (RSI) of 56 leaves it in the technically neutral range between the attract5ive oversold buy signal of 30 and the overbought RSI sell signal of 70. Allied Properties REIT, Ballard Power Systems Inc. and Canopy Growth are really, really oversold with RSIs below 20. Element Fleet Management Corp., Energy Fuels Inc., Tilray Brands Inc., Air Canada and Labrador Iron Ore Royalty Co. are also oversold. There are 18 overbought, technically vulnerable stocks this week led by Dollarama Inc., Loblaw Companies Ltd., Suncor Energy, George Weston Ltd. and Metro Inc. There are no benchmark constituents showing strong price momentum by hitting new 52-week highs. Stocks hitting new lows include Telus Corp., Boardwalk REIT, H&R REIT and Allied Properties REIT.

Daily roundup of research and analysis from The Globe and Mail’s market strategist Scott BarlowTop picks in energy sectorScotiabank analyst Kevin Fisk’s report “It’s easier paddling downstream” provided top picks in the energy sector,“While acknowledging that Canadian producers generally trade at a premium versus U. S. peers, we believe valuations remain attractive in absolute terms given strong inventory depth, future growth optionality, FCF duration, and robust shareholder returns. We maintain a strong preference for oil-weighted equities and companies with downstream exposure given robust oil prices and exceptionally strong refining margins. We have refreshed our pecking order and highlight SU, CVE, OVV, and TVE as our top picks … On average, our target prices increased by 6 per cent, led by VET (up 18 per cent), IMO (up 17 per cent) SU (up 16 per cent), IPCO (up 16 per cent), WCP (up 16 per cent), SDE (up 13 per cent) and BTE (up 13 per cent). Conversely, we have trimmed targets on AAV (down 10 per cent), PEY (down 5 per cent) and TOU (down 4 per cent), reflecting the shift to strip natural gas prices.